Evidence map›Paper›PMID 32117091›Full record

ArticleFrontiers in microbiology2020

The E3 Ubiquitin Ligase SIAH1 Targets MyD88 for Proteasomal Degradation During Dengue Virus Infection.

Ashleigh R Murphy Schafer, Jessica L Smith, Kara M Pryke, Victor R DeFilippis, Alec J Hirsch

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Innate and adaptive immune evasion by dengue virus.Frontiers in cellular and infection microbiology · 2022
    Review
  12. Review
  13. Review
  14. Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Ashleigh R Murphy SchaferVaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR, United States.
Jessica L SmithVaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR, United States.
Kara M PrykeVaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR, United States.
Victor R DeFilippisVaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR, United States.
Alec J HirschVaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR, United States.
Oregon Health & Science University · USChildren's Cancer Therapy Development Institute · US

Funding

Screening CoreU19AI109680 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI STREBLOW, DANIEL N · 2014 to 2018
$34.9M
The Administrative CoreP01AI127335 · NIAID · OREGON HEALTH & SCIENCE UNIVERSITY · PI Patrizia Caposio · 2017 to 2026
$24.6M
PATHOGENESIS AND IMMUNOLOGY OF DISEASET32AI007244 · NIAID · SCRIPPS RESEARCH INSTITUTE, THE · PI NEMAZEE, DAVID · 1985 to 2022
$8.8M
Training Program in VirologyT32AI074494 · NIAID · OREGON HEALTH & SCIENCE UNIVERSITY · PI NELSON, JAY A · 2009 to 2013
$1.1M
Evaluation of Host miRNAs as Therapeutics against Encephalitogenic FlavivirusesR21AI101282 · NIAID · OREGON HEALTH & SCIENCE UNIVERSITY · PI HIRSCH, ALEC J · 2012 to 2013
$477k
MINORITY PREDOCTORAL FELLOWSHIP PROGRAMF31AI010128 · NIAID · EASTERN VIRGINIA MEDICAL SCHOOL · PI DALTON, BRIDGET L · 1998 to 2000
$18k
NIAID NIH HHS F31 AI010128NIAID NIH HHS P01 AI127335NIAID NIH HHS R21 AI101282NIAID NIH HHS T32 AI007244NIAID NIH HHS T32 AI074494NIAID NIH HHS U19 AI109680
6 · The paper itself

Abstract

The dengue virus presents a serious threat to human health globally and can cause severe, even life-threatening, illness. Dengue virus (DENV) is endemic on all continents except Antarctica, and it is estimated that more than 100 million people are infected each year. Herein, we further mine the data from a previously described screen for microRNAs (miRNAs) that block flavivirus replication. We use miR-424, a member of the miR-15/16 family, as a tool to further dissect the role of host cell proteins during DENV infection. We observed that miR-424 suppresses expression of the E3 ubiquitin ligase SIAH1, which is normally induced during dengue virus 2 (DENV2) infection through activation of the unfolded protein response (UPR). Specific siRNA-mediated knockdown of SIAH1 also results in inhibition of DENV replication, demonstrating that this target is at least partly responsible for the antiviral activity of miR-424. We further show that SIAH1 binds to and ubiquitinates the innate immune adaptor protein MyD88 and that the antiviral effect of SIAH1 knockdown is reduced in cells in which MyD88 has been deleted by CRISPR/Cas9 gene editing. Additionally, MyD88-dependent signaling, triggered either by DENV2 infection or the Toll-like receptor 7 (TLR7) ligand imiquimod, is increased in cells in which SIAH1 has been knocked down by miR-424 or a SIAH1-specific siRNA. These observations suggest an additional pathway by which DENV2 harnesses aspects of the UPR to dampen the host innate immune response and promote viral replication.

Indexed as

dengueflavivirusmicroRNAubiquitinunfolded protein response

Identifiers

PMID32117091
PMCPMC7033647
OpenAlexW3006200932

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.